仅供参考。不构成财务建议。
YD Bio Limited Warrants（YDESW）在 医疗保健 行业运营，最新报价为 $0.53，市值为 $1.76M。
当前关键数据
翻译版分析（2026年4月17日）早于当前英文分析（2026年6月14日），因此不予显示。以下数据与英文页面来自同一数据源。 阅读最新英文分析
- 价格: $0.53 (2026年10月6日)
- 当日涨跌: -14.56%
- 市值: $1.76M
- 行业板块: 医疗保健
YDESW 的竞争对手是谁？
下表将 YDESW 与 8 家同行在价格、市值和我们的 AI MoonshotScore 上进行比较。
| 公司 | 价格 | 市值 | MoonshotScore |
|---|---|---|---|
| RLYB Rallybio Corporation | $16.93 | $89.9M | 82 |
| ANTX AN2 Therapeutics, Inc. | $4.85 | $175M | 65 |
| ORMP Oramed Pharmaceuticals Inc. | $4.37 | $181M | 76 |
| NAGE Niagen Bioscience Inc | $2.72 | $217M | 69 |
| PLX Protalix BioTherapeutics, Inc. | $2.71 | $218M | 62 |
| QTTB Q32 Bio Inc. | $7.99 | $238M | 66 |
| CRMD CorMedix Inc. | $7.28 | $571M | 94 |
| CLYM Climb Bio, Inc. | $10.71 | $611M | 68 |
AI 评分来自 Stock Expert AI · 价格数据：FMP / Yahoo Finance
最新新闻
-
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
Yahoo! Finance: YDESW News · 37 天前
-
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
Yahoo! Finance: YDESW News · 43 天前
-
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
Yahoo! Finance: YDESW News · 57 天前
数据仅供参考。